LILRA1 Antikörper (AA 401-489) (AbBy Fluor® 488)
-
- Target Alle LILRA1 Antikörper anzeigen
- LILRA1 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (With TM Domain), Member 1 (LILRA1))
-
Bindungsspezifität
- AA 401-489
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LILRA1 Antikörper ist konjugiert mit AbBy Fluor® 488
-
Applikation
- Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Homologie
- Human
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human LIR6
- Isotyp
- IgG
- Top Product
- Discover our top product LILRA1 Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- LILRA1 (Leukocyte Immunoglobulin-Like Receptor, Subfamily A (With TM Domain), Member 1 (LILRA1))
- Andere Bezeichnung
- LIR-6 (LILRA1 Produkte)
- Synonyme
- CD85I antikoerper, LIR-6 antikoerper, LIR6 antikoerper, leukocyte immunoglobulin like receptor A1 antikoerper, LILRA1 antikoerper
- Hintergrund
-
Synonyms: CD85 antigen-like family member I, CD85i, Leukocyte immunoglobulin-like receptor 6, Leukocyte immunoglobulin-like receptor subfamily A member 1, Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1, Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 soluble isoform, LILRA1, LIR-6, LIR6, LIRA1_HUMAN.
Background: May act as receptor for class I MHC antigens.
-